Darryl Hudson

D. Darryl Hudson (born Lethbridge, Alberta, 1982) is a Canadian scientist and musician based in Alberta, who specializes in the breeding, cultivation, extraction and formulation of Cannabis (drug). Hudson received his PhD in molecular biology and genetics from Guelph University in 2010 specializing in genetic engineering of crop plants. Dr. Hudson also performs studies and clinical research on psilocybin (magic mushrooms), and is the co-founder of Sansero Life Sciences Inc., a psychedelic pharmaceutical company based in Canada. 
Hudson is an expert in Cannabis industry and has contributed to a groundbreaking study of the genetics of Cannabis. Actively breeding hemp crops in Canada and abroad, Hudson has pioneered Cannabis extraction protocols focusing on efficient and safe methods for removal and separation of medical molecules from plants.
Hudson has been active in studying effects of Cannabis in treating post traumatic stress disorder (PTSD) specifically working with military veterans to develop both medications and protocols.< Hudson spoke to the US Senate, prior to the groundbreaking legislation that allowed US veterans to receive recommendations for medical marijuana. He continues to speak at many international conferences and acts as a judge at Cannabis competitions internationally.
Hudson is also co-author of numerous peer-reviewed scientific publications and research articles, on plant biology, plant genetics, DNA repair, epigenetics, cancer and Cannabis.
He is the founder of InPlanta Biotechnology and Pathways Rx, and continues to operate a lab in Canada focusing on Cannabis plant and its interactions with humans.